Cover Image

Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Objective: CSE-1034 is a novel antibiotic adjuvant entity (AAE) with proven activity against broad range of multi-drug resistant (MDR) pathogens causing various bacterial infections. This phase 3 clinical trial was designed to evaluate the efficacy and safety of CSE-1034 therapy for the treatment of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Manu Chaudhary (Author), Shiekh G. Ayub (Author), Mohd A. Mir (Author)
Format:	Book
Published:	Elsevier, 2018-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of Cineole (Soledum®) in the treatment of patients with acute bronchitis: results of an open-label randomized clinical phase III study
by: Peter Kardos, et al.
Published: (2021)

Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study
by: Yu Q, et al.
Published: (2018)

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis
by: Michael J. Cork, et al.
Published: (2023)

Efficacy and safety of decamethoxin in complex treatment of patients with group III viral-bacterial community-acquired pneumonia
by: O.L. Bororova
Published: (2021)

A set of essentials for online learning: CSE-SET
by: J. Dulangi Kanchana, et al.
Published: (2023)

Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
by: Brett King, et al.
Published: (2022)

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
by: Amy S. Paller, et al.
Published: (2023)

Comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
by: Sonia Shinde Mahajan, et al.
Published: (2019)

Skeletal Muscle CSE Deficiency Leads to Insulin Resistance in Mice
by: Miaomiao Xu, et al.
Published: (2022)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019)

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
by: Wang X, et al.
Published: (2020)

Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open‐label, multiple‐dose study
by: Andrew D. Hershey, et al.
Published: (2024)

A phase I, open‐label, single‐dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib
by: Ling Gao, et al.
Published: (2023)

Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation
by: Edmund H. Jooste, et al.
Published: (2017)

Hereditary spherocytosis due to a novel variant, p.Q1034X, in the beta subunit of the spectrin gene: A case report
by: Emmalee M. Kugler, et al.
Published: (2024)

An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
by: Hidehisa Saeki, et al.
Published: (2024)

The Effect Of Core Stability Exercise (CSE) On Balance In Primary School Students
by: Anggi Setia Lengkana, et al.
Published: (2019)

The Effect Of Core Stability Exercise (CSE) On Balance In Primary School Students
by: Anggi Setia Lengkana, et al.
Published: (2019)

ΔMST and the Regulation of Cardiac CSE and OTR Expression in Trauma and Hemorrhage
by: Britta Trautwein, et al.
Published: (2021)

Efficacy and safety of external trigeminal neurostimulation in the prevention of chronic migraine: An open-label trial
by: Marius Birlea, et al.
Published: (2019)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012)

Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study
by: Thierry Passeron, et al.
Published: (2024)

Open-label phase I clinical trial of Ad5-EBOV in Africans in China
by: Lihua Wu, et al.
Published: (2017)

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma
by: Astrid De Meulenaere, et al.
Published: (2021)

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
by: Olivier Godeaux, et al.
Published: (2017)

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
by: Asmik Asatryan, et al.
Published: (2021)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022)

Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
by: A. L. Bakulev, et al.
Published: (2019)

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
by: Sang Youb Han, et al.
Published: (2022)

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
by: Nicolino Ruperto, et al.
Published: (2017)

Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study
by: H R Jerajani, et al.
Published: (2011)

Efficacy and safety of etanercept in the treatment of recalcitrant psoriasis: An open-label, retrospective, observational study in Taiwan
by: Yi-Fang Wu, et al.
Published: (2013)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
by: Rozita Doosti, et al.
Published: (2021)

Safety of long-term use of linezolid: results of an open-label study
by: Vazquez JA, et al.
Published: (2016)

Open-Label Study of the Safety and Pharmacokinetics of Solifenacin in Subjects With Hepatic Impairment
by: Mirjam Kuipers, et al.
Published: (2006)

Pneumonia acquired in the Community
by: María Caridad Fragoso Marchante, et al.
Published: (2007)

Pneumonia acquired in the Community
by: María Caridad Fragoso Marchante, et al.
Published: (2007)

Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open‐label, phase I study in healthy subjects
by: Masaya Tachibana, et al.
Published: (2023)

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022)

PENGEMBANGAN CSE-KTD UNTUK MENINGKATKAN KETERAMPILAN EPS DAN PENGUASAAN KONSEP MAHASISWA
by: Nurhamida Anar, -
Published: (2023)